Table 2. Meta-analysis of SNPs validated in the phase II.

CHR	Gene†	SNPs	BP‡	A1	P	P(R)	OR	OR(R)	Q	I
4q26	NDST3	rs3987*	118978503	C	4.02E-08	4.02E-08	1.36	1.36	0.94	0
4q26	NDST3	rs1023890*	118920894	A	5.61E-08	5.61E-08	1.36	1.36	0.90	0
4q26	NDST3	rs1870481	118882468	T	1.23E-07	1.23E-07	1.35	1.35	0.99	0
4q26	NDST3	rs2169059	118926638	A	2.04E-07	2.04E-07	1.34	1.34	0.93	0
4q26	NDST3	rs1459528	118969796	G	4.57E-07	4.57E-07	1.33	1.33	0.74	0
4q32.1	FAM198B	rs2881373	159312083	T	6.86E-06	6.86E-06	1.39	1.39	0.35	0
5p15.1	MYO10	rs588367	16709570	A	0.000013	0.007262	0.76	0.76	0.10	62.7
5p15.1	MYO10	rs428263	16711495	T	0.000026	0.003224	0.77	0.77	0.15	51.5
5p15.1	MYO10	rs876095	16709803	T	0.00003	0.00312	0.77	0.77	0.15	50.5
12q23.1	AK307646	rs3858655*	95404373	T	0.000147	0.000147	1.34	1.34	0.63	0
12q23.1	AK307646	rs17375557*	95442660	A	0.000175	0.000175	1.33	1.33	0.60	0
11q24.1	SORL1	rs11218350*	120957861	T	0.000179	0.000179	1.28	1.28	0.61	0
4q32.1	TMEM144	rs7664129*	159189132	C	0.000197	0.000197	1.35	1.35	0.38	0
13q14.11	ENOX1	rs4941455*	42799471	A	0.001042	0.001042	0.77	0.77	0.57	0
9p13.2	PAX5	rs11999298*	36884151	T	0.005207	0.005207	1.38	1.38	0.92	0

CHR: Chromosome; SNP: Single Nucleotide Polymorphism; BP: Base pair position; A1: Reference allele (minor allele); P: Fixed-effects p-value; P(R): Random-effects p-value; OR: Fixed-effects Odds Ratio; OR(R): Random-effects Odds Ratio; Q: p-value for heterogeneity of OR; I: effect size for heterogeneity of OR.

*SNPs selected by two-locus association analyses in the NXC-GWAS sample.

^†The nearest gene or the gene where the SNP is located.

^‡According to UCSC genome browser (NCBI36/hg18) and dbSNP build 130.